Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Gastrointestinal Stromal Tumor (GIST) 31 May 24, 2016: Arog Pharmaceuticals Presents Crenolanib Clinical Data at the 2016 American Society of Clinical Oncology Annual Meeting 31 Apr 20, 2016: Kolltan Pharmaceuticals Announces Presentations of Anti-KIT Antibody Preclinical Data at the 2016 American Association for Cancer Research Annual Meeting 31 Clinical Trial Profile Snapshots 33 Appendix 299 Abbreviations 299 Definitions 299 Research Methodology 300 Secondary Research 300 About GlobalData 301 Contact Us 301 Disclaimer 301 Source 302

List of Tables Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region, 2016* 6 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 List of Figures Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Gastrointestinal Stromal Tumor (GIST) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Gastrointestinal Stromal Tumor (GIST) to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Gastrointestinal Stromal Tumor (GIST) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Gastrointestinal Stromal Tumor (GIST) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Gastrointestinal Stromal Tumor (GIST) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Gastrointestinal Stromal Tumor (GIST) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30 GlobalData Methodology 300

Novartis AG Pfizer Inc. Bayer AG AB Science SA GlaxoSmithKline Plc F. Hoffmann-La Roche Ltd. Veeda Clinical Research Limited Merck & Co., Inc. Otsuka Pharmaceutical Co., Ltd. Otsuka Holdings Co., Ltd.